NFKB1 and neoplasm: Since NF-kB and inflammation have been linked to Kras mutations and cancer development, inhibitor of NF-kB kinase subunit b (IKK2) depletion in lung tumor cells significantly attenuates tumor proliferation and prolongs mouse survival (120).